These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3012745)

  • 1. [Activation of latent infections caused by the Epstein-Barr virus in systemic lupus erythematosus].
    Anan'eva LP; Alekberova ZS; Nasonova VA; Stepina VN
    Revmatologiia (Mosk); 1986; (1):39-43. PubMed ID: 3012745
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of Epstein-Barr virus antibody production in systemic lupus erythematosus patients.
    Stancek D; Robenský J
    Acta Virol; 1979 Mar; 23(2):168-9. PubMed ID: 39442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epstein-Barr virus and its role in various rheumatic diseases].
    Anan'eva LP; Alekberova ZS; Barinskii IF; Nasonova VA
    Ter Arkh; 1983; 55(7):140-6. PubMed ID: 6312625
    [No Abstract]   [Full Text] [Related]  

  • 4. High titer of antibody to the Epstein-Barr virus membrane antigen in sera from patients with rheumatoid arthritis and systemic lupus erythematosus.
    Yokochi T; Yanagawa A; Kimura Y; Mizushima Y
    J Rheumatol; 1989 Aug; 16(8):1029-32. PubMed ID: 2555505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus and systemic lupus erythematosus.
    James JA; Harley JB; Scofield RH
    Curr Opin Rheumatol; 2006 Sep; 18(5):462-7. PubMed ID: 16896283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactions of sera from patients with rheumatoid arthritis, systemic lupus erythematosus and infectious mononucleosis to Epstein-Barr virus-induced polypeptides.
    Sculley DG; Sculley TB; Pope JH
    J Gen Virol; 1986 Oct; 67 ( Pt 10)():2253-8. PubMed ID: 3020161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-cell control of herpesvirus infections: lessons from the Epstein-Barr virus.
    Rickinson AB
    Prog Brain Res; 1983; 59():189-202. PubMed ID: 6320264
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular mimicry in systemic lupus erythematosus.
    Agmon-Levin N; Blank M; Paz Z; Shoenfeld Y
    Lupus; 2009 Nov; 18(13):1181-5. PubMed ID: 19880565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Epstein-Barr virus antibodies in systemic lupus erythematosus.
    Origgi L; Perego R; Hu C; Bertetti E; D'Agostino P; Asero R; Riboldi P
    Boll Ist Sieroter Milan; 1988; 67(2):116-22. PubMed ID: 2852506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus-specific cytoskeletal early antigen in EBV-transformed cell lines.
    Sairenji T; Nguyen QV; Woda B; Humphreys RE
    AIDS Res; 1986 Dec; 2 Suppl 1():S57-60. PubMed ID: 3030348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antibody formation against specific Epstein-Barr virus antigens in infectious mononucleosis with tonsillectomy in the acute phase of the disease].
    Sauerbrei A; Sprössig M; Wutzler P; Färber I; Schweizer H; Swoboda R; Wilke J
    Laryngol Rhinol Otol (Stuttg); 1983 Apr; 62(4):170-4. PubMed ID: 6191167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of infectious mononucleosis and other complications of Epstein-Barr virus infections.
    Purtilo DT
    Pathol Annu; 1980; 15(Pt 1):253-99. PubMed ID: 6255399
    [No Abstract]   [Full Text] [Related]  

  • 13. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
    Gray J; Wreghitt TG; Pavel P; Smyth RL; Parameshwar J; Stewart S; Cary N; Large S; Wallwork J
    J Heart Lung Transplant; 1995; 14(4):640-6. PubMed ID: 7578169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus (herpes-type virus) antibodies in connective tissue diseases.
    Stevens DA; Stevens MB; Newell GR; Levine PH; Waggoner DE
    Arch Intern Med; 1972 Jul; 130(1):23-8. PubMed ID: 4338539
    [No Abstract]   [Full Text] [Related]  

  • 15. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-barr-virus nuclear antigen.
    Vonka V; Hirsch I
    Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
    [No Abstract]   [Full Text] [Related]  

  • 17. [Analysis of viral capsid anti-antigen antibodies of the Epstein Barr virus in infectious mononucleosis. Comparative evaluation of a fluorescence method with classic methods].
    Picerno G; Lari M; Fregoso F; Musmanno G
    Quad Sclavo Diagn; 1983 Dec; 19(4):489-98. PubMed ID: 6330785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Leukocyte migration inhibition elicited by Epstein-Barr virus antigen. Reaction potential in infectious mononucleosis as well as in states of immune deficiency and immunosuppression].
    Szigeti R; Klein E; Masucci MG; Ernberg I; Masucci G; Svedmyr E; Klein G
    Orv Hetil; 1982 May; 123(20):1217-21. PubMed ID: 6287380
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antibodies against non-structural antigens of Epstein-Barr virus in children with infectious mononucleosis].
    Najberg G
    Med Dosw Mikrobiol; 1983; 35(1):55-9. PubMed ID: 6314071
    [No Abstract]   [Full Text] [Related]  

  • 20. The Epstein-Barr virus (EBV) in human pathology. Results of a serological investigation of a hospital population.
    Dalens M; Didier J; Pris J; Enjalbert L
    Biomedicine; 1973 Jul; 18(4):336-45. PubMed ID: 4139980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.